Table 2.

Medical expenditures (in US dollars) during the 1-year post-operative period for newly diagnosed ovarian cancer patients.

	Total		OOP		Insurance		COB
	Median	(IQR)	Median	(IQR)	Median	(IQR)	Median	(IQR)
Total	93,632	(62,319–140,140)	2,988	(1,649–5,088)	81,628	(43,972–132,100)	0	(0–0)
Inpatient services	30,708	(20,102–51,107)	589	(3–1,715)	25,727	(13,485–44,327)	0	(0–0)
Outpatient services	52,700	(31,210–83,206)	1,509	(705–2,878)	45,201	(19,127–78,078)	0	(0–0)
Outpatient drugs	1,814	(603–4,402)	351	(149–656)	1,360	(370–3,662)	0	(0–0)

OOP (out-of-pocket), insurance liability, and COB (coordination of benefits and other savings) for inpatient, outpatient services and outpatient drugs were winsorized at 3rd & 97th percentiles, then summed to get the inpatient, outpatient services, outpatient drugs, and total medical expenditures (including inpatient, outpatient services and outpatient drugs).